purchase customization

1 Study Coverage
1.1 Human Growth Hormone Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Norditropin
1.2.3 Genotropin
1.2.4 Humatrope
1.2.5 Saizen
1.2.6 Omnitrope - the Somatropin Biosimilar
1.2.7 Somatropin Biopartners
1.3 Market by Application
1.3.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prader-Willi Syndrome
1.3.3 Turner Syndrome
1.3.4 Short Stature Homeobox Gene
1.3.5 Small for Gestational Age
1.3.6 Chronic Renal Insufficiency
1.3.7 Short Bowel Syndrome
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Growth Hormone Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Human Growth Hormone Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Growth Hormone Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Growth Hormone Drugs Sales by Region
2.4.1 Global Human Growth Hormone Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Human Growth Hormone Drugs by Region (2023-2028)
2.5 Global Human Growth Hormone Drugs Revenue by Region
2.5.1 Global Human Growth Hormone Drugs Revenue by Region (2017-2022)
2.5.2 Global Human Growth Hormone Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Growth Hormone Drugs Sales by Manufacturers
3.1.1 Global Top Human Growth Hormone Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Human Growth Hormone Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Growth Hormone Drugs in 2021
3.2 Global Human Growth Hormone Drugs Revenue by Manufacturers
3.2.1 Global Human Growth Hormone Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Growth Hormone Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Growth Hormone Drugs Revenue in 2021
3.3 Global Human Growth Hormone Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Growth Hormone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Growth Hormone Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Growth Hormone Drugs Sales by Type
4.1.1 Global Human Growth Hormone Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Human Growth Hormone Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Growth Hormone Drugs Sales Market Share by Type (2017-2028)
4.2 Global Human Growth Hormone Drugs Revenue by Type
4.2.1 Global Human Growth Hormone Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Human Growth Hormone Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Growth Hormone Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Human Growth Hormone Drugs Price by Type
4.3.1 Global Human Growth Hormone Drugs Price by Type (2017-2022)
4.3.2 Global Human Growth Hormone Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Growth Hormone Drugs Sales by Application
5.1.1 Global Human Growth Hormone Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Human Growth Hormone Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Growth Hormone Drugs Sales Market Share by Application (2017-2028)
5.2 Global Human Growth Hormone Drugs Revenue by Application
5.2.1 Global Human Growth Hormone Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Human Growth Hormone Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Growth Hormone Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Human Growth Hormone Drugs Price by Application
5.3.1 Global Human Growth Hormone Drugs Price by Application (2017-2022)
5.3.2 Global Human Growth Hormone Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Growth Hormone Drugs Market Size by Type
6.1.1 North America Human Growth Hormone Drugs Sales by Type (2017-2028)
6.1.2 North America Human Growth Hormone Drugs Revenue by Type (2017-2028)
6.2 North America Human Growth Hormone Drugs Market Size by Application
6.2.1 North America Human Growth Hormone Drugs Sales by Application (2017-2028)
6.2.2 North America Human Growth Hormone Drugs Revenue by Application (2017-2028)
6.3 North America Human Growth Hormone Drugs Market Size by Country
6.3.1 North America Human Growth Hormone Drugs Sales by Country (2017-2028)
6.3.2 North America Human Growth Hormone Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Growth Hormone Drugs Market Size by Type
7.1.1 Europe Human Growth Hormone Drugs Sales by Type (2017-2028)
7.1.2 Europe Human Growth Hormone Drugs Revenue by Type (2017-2028)
7.2 Europe Human Growth Hormone Drugs Market Size by Application
7.2.1 Europe Human Growth Hormone Drugs Sales by Application (2017-2028)
7.2.2 Europe Human Growth Hormone Drugs Revenue by Application (2017-2028)
7.3 Europe Human Growth Hormone Drugs Market Size by Country
7.3.1 Europe Human Growth Hormone Drugs Sales by Country (2017-2028)
7.3.2 Europe Human Growth Hormone Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Growth Hormone Drugs Market Size by Type
8.1.1 Asia Pacific Human Growth Hormone Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Growth Hormone Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Human Growth Hormone Drugs Market Size by Application
8.2.1 Asia Pacific Human Growth Hormone Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Growth Hormone Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Human Growth Hormone Drugs Market Size by Region
8.3.1 Asia Pacific Human Growth Hormone Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Growth Hormone Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Growth Hormone Drugs Market Size by Type
9.1.1 Latin America Human Growth Hormone Drugs Sales by Type (2017-2028)
9.1.2 Latin America Human Growth Hormone Drugs Revenue by Type (2017-2028)
9.2 Latin America Human Growth Hormone Drugs Market Size by Application
9.2.1 Latin America Human Growth Hormone Drugs Sales by Application (2017-2028)
9.2.2 Latin America Human Growth Hormone Drugs Revenue by Application (2017-2028)
9.3 Latin America Human Growth Hormone Drugs Market Size by Country
9.3.1 Latin America Human Growth Hormone Drugs Sales by Country (2017-2028)
9.3.2 Latin America Human Growth Hormone Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Growth Hormone Drugs Market Size by Type
10.1.1 Middle East and Africa Human Growth Hormone Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Growth Hormone Drugs Market Size by Application
10.2.1 Middle East and Africa Human Growth Hormone Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Growth Hormone Drugs Market Size by Country
10.3.1 Middle East and Africa Human Growth Hormone Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Eli Lilly and Company (US)
11.1.1 Eli Lilly and Company (US) Corporation Information
11.1.2 Eli Lilly and Company (US) Overview
11.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly and Company (US) Recent Developments
11.2 Ferring Holding SA (Switzerland)
11.2.1 Ferring Holding SA (Switzerland) Corporation Information
11.2.2 Ferring Holding SA (Switzerland) Overview
11.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ferring Holding SA (Switzerland) Recent Developments
11.3 Genentech, Inc. (US)
11.3.1 Genentech, Inc. (US) Corporation Information
11.3.2 Genentech, Inc. (US) Overview
11.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Genentech, Inc. (US) Recent Developments
11.4 GeneScience Pharmaceuticals Co., Ltd. (China)
11.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Corporation Information
11.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Overview
11.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Developments
11.5 Merck KgaA (Germany)
11.5.1 Merck KgaA (Germany) Corporation Information
11.5.2 Merck KgaA (Germany) Overview
11.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck KgaA (Germany) Recent Developments
11.6 Novo Nordisk A/S (Denmark)
11.6.1 Novo Nordisk A/S (Denmark) Corporation Information
11.6.2 Novo Nordisk A/S (Denmark) Overview
11.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novo Nordisk A/S (Denmark) Recent Developments
11.7 Pfizer, Inc. (US)
11.7.1 Pfizer, Inc. (US) Corporation Information
11.7.2 Pfizer, Inc. (US) Overview
11.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer, Inc. (US) Recent Developments
11.8 Sandoz International GmbH (Germany)
11.8.1 Sandoz International GmbH (Germany) Corporation Information
11.8.2 Sandoz International GmbH (Germany) Overview
11.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sandoz International GmbH (Germany) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Growth Hormone Drugs Industry Chain Analysis
12.2 Human Growth Hormone Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Growth Hormone Drugs Production Mode & Process
12.4 Human Growth Hormone Drugs Sales and Marketing
12.4.1 Human Growth Hormone Drugs Sales Channels
12.4.2 Human Growth Hormone Drugs Distributors
12.5 Human Growth Hormone Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Growth Hormone Drugs Industry Trends
13.2 Human Growth Hormone Drugs Market Drivers
13.3 Human Growth Hormone Drugs Market Challenges
13.4 Human Growth Hormone Drugs Market Restraints
14 Key Findings in The Global Human Growth Hormone Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer